Aurora Cannabis Inc.

As of June 30, 2026, Aurora Cannabis Inc. carries a market capitalization of 155.62M, placing it among publicly traded companies globally. Its enterprise value stands at 107.91M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Aurora Cannabis Inc.'s next confirmed earnings release is scheduled for November 11, 2026.

As of June 30, 2026, Aurora Cannabis Inc. has 63.31M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.80, and the price-to-book ratio stands at 0.48.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.60 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 107.91M versus a market cap of 155.62M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Aurora Cannabis Inc. maintains a current ratio of 5.36, meaning it holds 5.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.30, indicating elevated leverage, while an interest coverage ratio of -74.58 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Aurora Cannabis Inc. posted a negative return on equity (ROE) of -23.13, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -17.11, reflecting losses generated across the asset base. The company generates approximately 168,092.47 in revenue per employee across its workforce of 1,064.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.70 indicates how many times Aurora Cannabis Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Aurora Cannabis Inc. recorded 1.54M in income tax expense. The company reported a pretax loss of -25.14M and -76.96M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Aurora Cannabis Inc.'s stock has declined approximately 18.61% over the past 52 weeks. The 50-day moving average sits at 3.51, while the 200-day moving average is 3.06.

Over the twelve months ended June 30, 2026, Aurora Cannabis Inc. generated 178.93M in revenue and converted that into -76.96M in net income, yielding earnings per share of -0.46. EBITDA reached -22.91M, while operating income came in at -21.49M.

As of June 30, 2026, Aurora Cannabis Inc. holds 61.69M in cash and equivalents against 13.99M in total debt, resulting in a net debt position of -42.75M. Total book value stands at 325.11M, with working capital of 197.37M providing operational flexibility.

Aurora Cannabis Inc. produced -17.32M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -14.23M in capital expenditures, free cash flow totaled -31.55M - equivalent to -0.54 per share.

Over the twelve months ended June 30, 2026, Aurora Cannabis Inc. posted a gross margin of 49.74, reflecting its pricing power and cost economics. The operating margin of -12.01 and net profit margin of -43.01 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -22.04: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -7.32, meaning Aurora Cannabis Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Aurora Cannabis Inc.'s most recent stock split took place on February 21, 2024 with a 10:1 split ratio.

As of June 30, 2026, Aurora Cannabis Inc. has an Altman Z-Score of -13.48, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.